Daniel Ontaneda, MD
Enriched profileProfessor of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University · Cleveland Clinic
Daniel Ontaneda is Professor of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University at Cleveland Clinic. OpenAlex indexes 308 publications with 6,295 citations (h-index 42); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 21 Sept 2026
Overview
Updated 16 Oct 2026
Daniel Ontaneda, M.D., is Professor of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The public record shows 308 publications with 6,295 citations (h-index 42), centered on Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 10 companies, 2 NIH-funded awards (2020–2026).
- Most recent indexed publication: 2026 · Neurology and therapy
- Top research focus: Multiple Sclerosis Research Studies
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 69 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 102.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Central Vein Sign in Multiple Sclerosis Extension Study
Sponsor: The Cleveland Clinic
- Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
Sponsor: The Cleveland Clinic
- Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Sponsor: The Cleveland Clinic
Industry payments
Updated 16 Oct 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202510 payments$28,514openpaymentsdata.cms.gov ↗
- Genentech, Inc.Program year20251 payment
- TG Therapeutics, Inc.Program year20251 payment
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
50%gamma-Aminobutyric Acid-ergic Agonist50%Baclofen100%Part D<11 patientsNervous system
50%Potassium Channel Blocker50%Dalfampridine Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Susceptibility based MRI biomarkers for multiple sclerosis
Cleveland Clinic Lerner Com-Cwru
FY2026$549,500R56NS146394 - Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis
Cleveland Clinic Lerner Com-Cwru
FY2024$1,617,384U01NS116776 - Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis
Cleveland Clinic Lerner Com-Cwru
FY2023$1,834,261U01NS116776
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).
Multiple sclerosis (Houndmills, Basingstoke, England)
Clinical Trial2026 - Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
Article2026 - Paramagnetic rim lesions on 7T MRI after autologous hematopoietic cell transplantation.
Multiple sclerosis (Houndmills, Basingstoke, England)
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaArticle342 citations2025
- 03
- 04Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisArticle288 citations2018
- 05Clinical trials in progressive multiple sclerosis: lessons learned and future perspectivesArticle220 citations2015
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/daniel-ontaneda-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/daniel-ontaneda-b89b6574
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Daniel-Ontaneda
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
consultqd.clevelandclinic.org/tag/daniel-ontaneda
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultqd.clevelandclinic.org ↗ - Other
my.clevelandclinic.org/podcasts/neuro-pathways/diagnostic-criteria-for-multiple-sclerosis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗ - Other
neuronext.org/profile/daniel-ontaneda-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neuronext.org ↗ - Other
forum.actrims.org/program-committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →forum.actrims.org ↗ - Other
neurologylive.com/authors/daniel-ontaneda-md-phd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - X / Twitter
Active on X (Twitter) as @DanOntaneda, posting MS research and conference commentary
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
Pontificia Universidad Católica del Ecuador
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Ph.D.
Case Western Reserve University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →forum.actrims.org ↗
- Member
International Advisory Committee on Clinical Trials in MS -- co-author of the 2024 McDonald diagnostic criteria for multiple sclerosis
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultqd.clevelandclinic.org ↗ - Editor for Topical Reviews
Multiple Sclerosis Journal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →journals.sagepub.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thelancet.com ↗
- Sylvia Lawry Fellowship Award
National Multiple Sclerosis Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thelancet.com ↗ - NIH KL2 Career Development (Career Transition) Award
Cleveland CTSA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thelancet.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Arthur McCullough, MD
Cleveland Clinic
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida